- ARAV Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Aravive (ARAV) 8-K9 Nov 213 of 5 (60%) patients achieved a partial response All 5 patients treated demonstrated tumor decrease from baselineFinancial data
Company Profile